A meta-analysis on the association between CYP3A5*3 and tacrolimus response in kidney transplant recipients revealed that CYP3A5*1 allele carriers had a higher risk of acute rejection and chronic nephrotoxicity than CYP3A5*3/*3 carriers. This evidence concerns the gene CYP3A5 and medical procedure.